Profit and Prudence: Navigating Psychedelic Commercialization Through Lessons from the Prescription Opioid Crisis
Author
Abstract
Suggested Citation
DOI: 10.1016/j.healthpol.2023.104934
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
References listed on IDEAS
- Sarah DeWeerdt, 2019. "Tracing the US opioid crisis to its roots," Nature, Nature, vol. 573(7773), pages 10-12, September.
- Rickard, Emily & Ozieranski, Piotr & Mulinari, Shai, 2019. "Evaluating the transparency of pharmaceutical company disclosure of payments to patient organisations in the UK," Health Policy, Elsevier, vol. 123(12), pages 1244-1250.
Most related items
These are the items that most often cite the same works as this one and are cited by the same works as this one.- Shiyu Zhang & Daniel Guth, 2021. "The OxyContin Reformulation Revisited: New Evidence From Improved Definitions of Markets and Substitutes," Papers 2101.01128, arXiv.org, revised Jan 2021.
- Eszter Saghy & Shai Mulinari & Piotr Ozieranski, 2021. "Drug company payments to General Practices in England: Cross-sectional and social network analysis," PLOS ONE, Public Library of Science, vol. 16(12), pages 1-16, December.
- Peter Congdon, 2020. "Geographical Aspects of Recent Trends in Drug-Related Deaths, with a Focus on Intra-National Contextual Variation," IJERPH, MDPI, vol. 17(21), pages 1-18, November.
- Roxana Damiescu & Mita Banerjee & David Y. W. Lee & Norbert W. Paul & Thomas Efferth, 2021. "Health(care) in the Crisis: Reflections in Science and Society on Opioid Addiction," IJERPH, MDPI, vol. 18(1), pages 1-17, January.
- Moriarty, Frank & Larkin, James & Fahey, Tom, 2021. "Payments reported by the pharmaceutical industry in Ireland from 2015 to 2019: An observational study," Health Policy, Elsevier, vol. 125(10), pages 1297-1304.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:eee:hepoli:v:138:y:2023:i:c:s0168851023002191. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Catherine Liu or the person in charge (email available below). General contact details of provider: http://www.elsevier.com/locate/healthpol .
Please note that corrections may take a couple of weeks to filter through the various RePEc services.